Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Bio-Path Holdings Inc (BPTH) USD0.001

Sell:$5.91 Buy:$6.34 Change: $0.02 (0.33%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
Sell:$5.91
Buy:$6.34
Change: $0.02 (0.33%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
Sell:$5.91
Buy:$6.34
Change: $0.02 (0.33%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. The Company's drug delivery and antisense technology, called DNAbilize, is a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by the body's enzymes when circulating in vivo, incorporated inside of a neutral charged lipid bilayer. In vivo, the DNAbilize delivered antisense drug substances are systemically distributed across the body to allow for reduction or elimination of proteins in blood diseases and solid organs. Using DNAbilize as a platform for drug manufacturing, the Company has approximately three antisense drug candidates in development to treat a total of over five different cancer disease indications.

Contact details

Address:
4710 Bellaire Blvd Ste 210
BELLAIRE
77401-4505
United States
Telephone:
+1 (832) 7421357
Website:
www.biopathholdings.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BPTH
ISIN:
US09057N3008
Market cap:
$42.38 million
Shares in issue:
6.95 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Peter Nielsen
    Chairman of the Board, President, Chief Executive Officer, Co-Founder, Chief Financial Officer, Treasurer
  • Douglas Morris
    Director, Secretary, Director of Investor Relations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.